Cascadian Therapeutics, Inc (CASC) - NASDAQ
From other sites
Company Description
Oncothyreon, Inc. is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. Its current clinical-stage product candidates include ONT-380, an orally active and selective small-molecule HER2 inhibitor, and ONT-10, a therapeutic... More
Sector: Healthcare
Industry: Biotechnology
Country: United States